# US 8,278,085 B2 · RNA processing protein complexes and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,085 B2
- Document ID: US8278085B2
- Status: Granted
- Kind: B2
- Application number: 12/317,899
- Filed: 2008-12-30
- Published: 2010-06-03
- Granted: 2012-10-02
- Earliest claimed: 2003-07-02
- Assignees: PTC Therapeutics, Inc.
- Inventors: Christopher R. Trotta; Sergey Paushkin
- Web page: https://patentgrep.com/patent/US8278085B2

## CPC

- C12Q 1/6897: involving reporter genes operably linked to promoters
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07K 14/47: from mammals
- C12N 9/22: Ribonucleases {[RNase]; Deoxyribonucleases [DNase]}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention provides human protein complexes with endonuclease activity, including tRNA splicing endonuclease activity and 3′ end pre-mRNA endonuclease activity, and pre-ribosomal RNA cleavage activity. The invention also provides a splice variant of human Sen2, and human protein complexes comprising the variant. The invention provides human protein complexes with pre-ribosomal RNA cleavage activity. The invention also provides antibodies that immunospecifically bind to a complex described herein or a component thereof, and uses of such antibodies. The present invention also provides methods of preparing and purifying the complexes and uses of the complexes inter alia, in screening, diagnosis, and therapy. The present invention further provides methods of identifying a compound that modulates the expression of a component of a complex described herein, the formation of a complex described herein or the activity of a complex described herein, and methods of preventing, treating, managing or ameliorating a disorder, such as a proliferative disorder, or a symptom thereof utilizing such a compound.

## Claims

### Claim 1

A purified complex, wherein the complex comprises:
(i) a protein comprising the amino acid sequence of SEQ ID NO: 2 (Sen2);
(ii) a protein comprising the amino acid sequence of SEQ ID NO: 4 (Sen15);
(iii) a protein comprising the amino acid sequence of SEQ ID NO: 6 (Sen34); and
(iv) a protein comprising the amino acid sequence of SEQ ID NO: 8 (Sen54).

### Claim 2 (depends on 1)

The complex of claim 1, further comprising a protein comprising the amino acid sequence of SEQ ID NO: 10 (Clp1).

### Claim 3

A purified complex having tRNA splicing endonuclease activity, wherein the complex comprises:
(i) a protein comprising the amino acid sequence of SEQ ID NO: 2 (Sen2), or a fusion protein comprising SEQ ID NO: 2 (Sen2) and a heterologous amino acid sequence;
(ii) a protein comprising the amino acid sequence of SEQ ID NO: 4 (Sen15), or a fusion protein comprising SEQ ID NO: 4 (Sen15) and a heterologous amino acid sequence;
(iii) a protein comprising the amino acid sequence of SEQ ID NO: 6 (Sen34), or a fusion protein comprising SEQ ID NO:6 (Sen34) and a heterologous amino acid sequence; and
(iv) a protein comprising the amino acid sequence of SEQ ID NO:8 (Sen54), or a fusion protein comprising SEQ ID NO:8 (Sen54) and a heterologous amino acid sequence.

### Claim 4 (depends on 3)

The complex of claim 3, wherein the complex further comprises a protein comprising the amino acid sequence of SEQ ID NO: 10 (Clp1), or a fusion protein comprising SEQ ID NO: 10 (Clp1) and a heterologous amino acid sequence.

### Claim 5 (depends on 3)

The complex of claim 3 which comprises a protein comprising the amino acid sequence of SEQ ID NO: 2 (Sen2).

### Claim 6 (depends on 3)

The complex of claim 3 which comprises a protein comprising the amino acid sequence of SEQ ID NO: 4 (Sen15).

### Claim 7 (depends on 3)

The complex of claim 3 which comprises a protein comprising the amino acid sequence of SEQ ID NO: 6 (Sen34).

### Claim 8 (depends on 3)

The complex of claim 3 which comprises a protein comprising the amino acid sequence of SEQ ID NO:8 (Sen54).

### Claim 9 (depends on 4)

The complex of claim 4 which comprises a protein comprising the amino acid sequence of SEQ ID NO: 10 (Clp1).

### Claim 10 (depends on 3)

The complex of claim 3, wherein the complex comprises:
(i) a fusion protein comprising SEQ ID NO: 2 (Sen2) and a heterologous amino acid sequence;
(ii) a fusion protein comprising SEQ ID NO: 4 (Sen15) and a heterologous amino acid sequence;
(iii) a fusion protein comprising SEQ ID NO:6 (Sen34) and a heterologous amino acid sequence; and
(iv) a fusion protein comprising SEQ ID NO:8 (Sen54) and a heterologous amino acid sequence.

### Claim 11 (depends on 10)

The complex of claim 10, wherein the complex further comprises a fusion protein comprising SEQ ID NO: 10 (Clp1), and a heterologous amino acid sequence.

### Claim 12 (depends on 1)

A composition comprising the complex of claim 1 and a carrier.

### Claim 13 (depends on 2)

A composition comprising the complex of claim 2 and a carrier.

### Claim 14 (depends on 3)

A composition comprising the complex of claim 3 and a carrier.

### Claim 15 (depends on 4)

A composition comprising the complex of claim 4 and a carrier.
